Clinical Trial Update: Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial evaluating sunitinib malate given before and after surgery in patients with previously untreated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Barts and the London School of Medicine and Dentistry | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED